Rafferty Asset Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $7.49M | Sell |
|
|||||
|
2024
Q1 | $9.4M | Buy |
|
|||||
|
2023
Q4 | $6M | Sell |
|
|||||
|
2023
Q3 | $4.34M | Buy |
|
|||||
|
2023
Q2 | $5.62M | Sell |
|
|||||
|
2023
Q1 | $5.13M | Sell |
|
|||||
|
2022
Q4 | $7.53M | Buy |
|
|||||
|
2022
Q3 | $4.27M | Buy |
|
|||||
|
2022
Q2 | $1.96M | Sell |
|
|||||
|
2022
Q1 | $3.96M | Sell |
|
|||||
|
2021
Q4 | $4.38M | Buy |
|
|||||
|
2021
Q3 | $2.42M | Buy |
|
|||||
|
2021
Q2 | $1.07M | Sell |
|
|||||
|
2021
Q1 | $846K | Buy |
|